Kriti Nutrients
Ticker > Company >

Kriti Nutrients share price

Kriti Nutrients Ltd.

  89.3 K   417   45 BSE: 533210 SECTOR: Edible Oil

77.49
-0.32 (-0.41%)
NSE: 25 Sep 4:00 PM

Buy on Angel One

Price Summary

Today's High

₹ 78.96

Today's Low

₹ 76.21

52 Week High

₹ 102.99

52 Week Low

₹ 51.36

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationAttractive
The stock is considerably attractive based on intrinsic value.
EfficiencyExcellent
The company knows very well the utilization of its assets.
FinancialsVery Stable
The company possesses stable growth history and manageable debt.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

₹ 388.25 Cr.

Enterprise Value

₹ 336.62 Cr.

No. of Shares

5.01 Cr.

P/E

11.52

P/B

1.63

Face Value

₹ 1

Div. Yield

3.88 %

Book Value (TTM)

₹  47.53

CASH

₹ 59.19 Cr.

DEBT

₹ 7.56 Cr.

Promoter Holding

66.68 %

EPS (TTM)

₹  6.72

Sales Growth

25.49%

ROE

15.35 %

ROCE

20.31%

Profit Growth

-8.6 %

Add Your Ratio

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.

PE Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

PB Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year25.49%
3 Year4.96%
5 Year5.96%

Profit Growth

1 Year-8.6%
3 Year17.62%
5 Year17.58%

ROE%

1 Year15.35%
3 Year21.25%
5 Year18.45%

ROCE %

1 Year20.31%
3 Year26.75%
5 Year23.05%

Debt/Equity

0.033

Price to Cash Flow

6.04

Interest Cover Ratio

83.3632

CFO/PAT (5 Yr. Avg.)

1.04123290002452

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Jun 2026 66.68 0.00
Mar 2026 66.68 0.00
Dec 2025 66.68 0.00
Sep 2025 66.68 0.00
Jun 2025 66.68 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good profit growth of 17.6170656689316% for the Past 3 years.
  • Company has been maintaining healthy ROE of 21.2465333333333% over the past 3 years.
  • Company has been maintaining healthy ROCE of 26.7466333333333% over the past 3 years.
  • Company is virtually debt free.
  • Company has a healthy Interest coverage ratio of 83.3632.
  • The company has an efficient Cash Conversion Cycle of 17.3188 days.
  • Company has a healthy liquidity position with current ratio of 3.6976.
  • The company has a good cash flow management; CFO/PAT stands at 1.04123290002452.
  • The company has a high promoter holding of 66.68%.

 Limitations

  • The company has shown a poor revenue growth of 4.96337793541981% for the Past 3 years.

Quarterly Result (All Figures in Cr.)

PARTICULARS Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026
Net Sales 229.04 212.94 224.31 255.23 247.08
Total Expenditure 217.67 201.69 212.8 245.91 235.27
Operating Profit 11.37 11.24 11.51 9.32 11.81
Other Income 2.05 2.42 1.91 1.6 1.67
Interest 0.12 0.12 0.12 0.19 0.24
Depreciation 1.44 1.43 1.44 1.45 1.52
Exceptional Items 0 0 0 0 0
Profit Before Tax 11.86 12.11 11.85 9.28 11.73
Tax 2.66 2.88 2.64 3.09 2.67
Profit After Tax 9.21 9.23 9.21 6.19 9.06
Adjusted EPS (Rs) 1.84 1.84 1.84 1.24 1.81

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Net Sales 752.88 796.87 684.36 734.34 921.51
Total Expenditure 733.56 765.68 622.15 686.31 878.08
Operating Profit 19.32 31.19 62.22 48.03 43.44
Other Income 3.35 4.44 4.45 7.76 7.97
Interest 2.11 3.53 1.39 0.57 0.55
Depreciation 3.73 4.16 4.69 5.44 5.75
Exceptional Items 0 0 0 0 0
Profit Before Tax 16.83 27.93 60.58 49.78 45.11
Tax 4.53 7.13 15.3 12.75 11.27
Net Profit 12.31 20.8 45.29 37.02 33.84
Adjusted EPS (Rs.) 2.46 4.15 9.04 7.39 6.75

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity and Liabilities
Share Capital 5.01 5.01 5.01 5.01 5.01
Total Reserves 107.49 127.36 171.48 206.88 224.06
Borrowings 0 0 0 0 0
Other N/C liabilities 7.29 7.1 6.56 6.54 6.46
Current liabilities 48.19 53.6 25.96 19.4 37.14
Total Liabilities 167.98 193.08 209.01 237.83 272.66
Assets
Net Block 47.29 48.53 58.09 57.59 56.54
Capital WIP 5.47 6.49 0.6 0.16 0.9
Intangible WIP 0 0 0 0 0
Investments 0 0 0 32.59 51.52
Loans & Advances 11.32 11.11 25.69 15.93 26.1
Other N/C Assets 0 0 10.65 36.33 0.28
Current Assets 103.9 126.94 113.98 95.22 137.32
Total Assets 167.98 193.08 209.01 237.83 272.66
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Profit from operations 16.83 27.93 60.58 49.78 45.11
Adjustment 2.75 3.42 3.53 0.02 -0.04
Changes in Assets & Liabilities -25.92 -3.76 1.73 -6.39 29.29
Tax Paid -4.17 -7.73 -16.03 -11.45 -10.07
Operating Cash Flow -10.51 19.86 49.81 31.96 64.29
Investing Cash Flow -19.98 -3.13 -29.19 -28.86 -9.35
Financing Cash Flow 31.19 -1.4 -30.4 -10.65 -10.39
Net Cash Flow 0.69 15.32 -9.77 -7.56 44.55

Corporate Actions

Investors Details

Annual Reports

Title Link
Title Link
Annual Report 2026
Annual Report 2020
Annual Report 2019
Annual Report 2018
Annual Report 2017

Ratings & Research Reports

TYPE AGENCY Link
TYPE AGENCY Link
Credit CARE
TYPE AGENCY Link
TYPE AGENCY Link
 No Research reports exist for this company.Report us

Concalls & Presentations

TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Concall related to this company.Report us
TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Presentation related to this company.Report us

Company News

Last Updated on:
Brief about Kriti Nutrients
X